— Know what they know.
Not Investment Advice

PRPH

ProPhase Labs, Inc.
1W: -10.0% 1M: -52.0% 3M: -89.5% YTD: -80.0% 1Y: -98.5% 3Y: -99.8% 5Y: -99.8%
$0.08
+0.01 (+7.64%)
 
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $367118 · Alpha Radar Sell · Power 35
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.4M
52W Range0.07-6.7
Volume33,683
Avg Volume454,591
Beta-0.52
Dividend
Analyst Ratings
1 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOTed William Karkus
Employees96
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1994-04-04
711 Stewart Avenue
Garden City, NY 11530
US
215 345 0919
About ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Recent Insider Trades

NameTypeSharesPriceDate
Karkus Ted William A-Award 500,000 $0.60 2025-09-09
Abenante Carolina 0 2025-06-20
Hollenshead Stuart A-Award 500,000 $0.60 2025-02-17
Hirsch Warren A-Award 100,000 $0.60 2025-02-14
GLECKEL LOUIS MD A-Award 100,000 $0.60 2025-02-14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms